Condition: Pancreatic Cancer · Pancreatic Adenocarcinoma · Metastatic Pancreatic Cancer · Sponsor: Alpha Tau Medical LTD.
This is a multi-center clinical study enrolling up to 30 participants (15 patients in each cohort). The primary objective of the study is to evaluate the safety of Alpha DaRT in combination with chemotherapy, based on the cumulative incidence rate, severity and outcome of device related AEs. Classification of AEs will be done according to CTCAE V5. The secondary objectives of the study are to: * Assess efficacy of the Alpha DaRT sources in combination with chemotherapy, determined by overall and progression-free survival. * Assess pain control * Assess rate of surgical resection in Cohort 1.
This description comes directly from the study's public registry record.
Liron Dimnik · +972-2-3737-7000 · LironD@alphatau.com
Always discuss trial participation with your own doctor first.
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| City of Hope | Goodyear, Arizona, United States | Not Yet Recruiting |
| Honor Health | Scottsdale, Arizona, United States | Recruiting |
| Cedars-Sinai | Los Angeles, California, United States | Not Yet Recruiting |
| Advent Health Cancer Institute | Orlando, Florida, United States | Not Yet Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Bassett Healthcare Network | Cooperstown, New York, United States | Recruiting |
| NYU Langone Health | New York, New York, United States | Recruiting |
| Lenox hill Hospital | New York, New York, United States | Not Yet Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
| Texas Oncology | Houston, Texas, United States | Not Yet Recruiting |
| Baylor College of Medicine | Houston, Texas, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06698458